Both in Pharmaceuticals
Citius Pharmaceuticals vs Dare Bioscience
Over the past year CTXR returned −63.2% and DARE returned −64.9%; their daily moves had a correlation of 0.12.
CTXR −63.2% DARE −64.9%Growth of $1, one year, split-adjusted
| Metric | CTXR | DARE |
|---|---|---|
| Price | $0.5732 | $0.6500 |
| Market cap | $15.7M | $12.8M |
| Today | +1.99% | −0.76% |
| 1 month | +10.2% | −22.9% |
| 6 months | −16.6% | −80.1% |
| Year to date | −26.2% | −66.3% |
| 1 year | −63.7% | −66.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | 67.1% | −70.6% |
| Net margin | −593.3% | −1590.4% |
| P/E (TTM) | — | — |
| Price / sales | 2.2× | 9.4× |
| Net cash | $10.6M | $12.5M |
| Dividend yield | — | — |
| Volatility (60d) | 96.6% | 99.5% |
| Short % of float | 21.9% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).